Creative Biolabs expands its CAR/TCR development capabilities with AI-driven solutions designed to support receptor candidate screening, prioritize engineered T-cell designs, and identify potential safety and specificity risks earlier in development.
The world's first case of an AI agent bypassing a national healthcare system's defenses accelerates the global cybersecurity emergency. Energieering expert Claudio Fratocchi: "The risk is no longer just human, but algorithmic."
Michael Bogdan Scholarship for Healthcare Announces New Opportunity for Undergraduate Students Pursuing Healthcare Careers
A Powerful Story of Healing, Consciousness, and Emotional Survival
New York Psychiatrist Supports Organization Focused on Brain Health, Scientific Innovation, Rehabilitation and Human-Centered Care
